Form 4: Marimed COO Reports Stock Transaction
Insider Transaction (Form 4)
Timothy Shaw, Chief Operating Officer of Marimed Inc., reported multiple transactions in common stock on October 2, 2026.
Summary
- Option exercise/conversion: acquired 9,981 Common stock on October 2, 2026; holds 9,464,581 after (Direct).
- Tax/exercise-price withholding: disposed of 3,459 Common stock at $0.07 ($241) on October 2, 2026; holds 9,461,122 after (Direct).
- Option exercise/conversion: disposed of 9,981 Restricted Stock Units (RSU) on October 2, 2026; holds 9,982 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Timothy Shaw — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Option exercise/conversion | Common stock | 9,981 | — | — | 9,464,581 |
| 2026-10-02 | Tax/exercise-price withholding | Common stock | 3,459 | $0 | $241 | 9,461,122 |
| 2026-10-02 | Option exercise/conversion | Restricted Stock Units (RSU) | 9,981 | — | — | 9,982 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Option exercise/conversion (9,981 shares) |
| 2026-10-02 | Tax/exercise-price withholding (3,459 shares) |
| 2026-10-02 | Option exercise/conversion (9,981 shares) |
Keywords
insider transaction, Form 4, MRMD, MARIMED INC., neutral, Timothy Shaw
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.